INS and type 2 diabetes mellitus: Interestingly, retrospective studies have shown a survival improvement in diabetic patients with many solid tumors, including pancreatic cancer, who have been treated with metformin (common drug for diabetes mellitus type 2 that is reported to enforce autophagy) compared with patients treated with insulin or sulfonylureas (72–74).